Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: FEMS Microbiol Lett. 2010 May 14;308(2):175–184. doi: 10.1111/j.1574-6968.2010.02012.x

Table 1.

Staphylococcus aureus strains used in this study

S. aureus strains Source, genotype, and phenotype description References
Wild-type strains
MW2 (NRS123) CA-MRSA; agr group III; spa type t128; ST1; PVL+ Baba et al. (2002)
FPR3757 (NRS384) CA-MRSA; agr group I; spa type t008; ST8; PVL+ Diep et al. (2008)
COL (NRS100) An early MRSA; ST250 Gill et al. (2005)
NCTC8325/RN6390 (NRS147) Laboratory strain; agr group I; ST8 Peng et al. (1988)
Newman A clinical isolate, routinely used as a laboratory strain; spa type t008 Baba et al. (2008)
MSSA476 Nosocomial strain; ST1 Holden et al. (2004)
N315 Nosocomial strain; ST5 Kuroda et al. (2001)
Mu50 Vancomycin-intermediate resistant Staphylococcus aureus; ST5 Hiramatsu et al. (1997)
Mutant strains
ALC355 Newman Δagr::tetM Wolz et al. (1996)
AS3 Newman sae::Tn917 Goerke et al. (2001)
IK184 Newman ΔrsbUVWsigB; Emr Kullik et al. (1998)
VKS104 Newman, Δagr::tetM/sigB::kanr This study

CA-MRSA, community-associated methicillin-resistant S. aureus.